Trial intelligence / Profile preview

Phase II study of MAX-40279-01 capsules in third-line or later advanced colorectal cancer

CTR20212927Phase 2Completed

Sponsor

Guangzhou Zaiji Medical Technology

Start

Apr 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1